International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 23 (3) , 243-257
- https://doi.org/10.2165/00019053-200523030-00005
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid ArthritisPharmacoEconomics, 2002
- Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal ToxicityPharmacoEconomics, 2001
- The Burden of Arthritis and Nonsteroidal Anti-Inflammatory TreatmentPharmacoEconomics, 2001
- A Review of the Direct Costs of Rheumatoid ArthritisPharmacoEconomics, 2001
- Choice of NSAID and Management Strategy in Rheumatoid Arthritis and OsteoarthritisPharmacoEconomics, 1998
- The Prevalence and Severity of Rheumatoid Arthritis in OsloScandinavian Journal of Rheumatology, 1997
- The Cost Effectiveness of Diclofenac Plus Misoprostol Compared with Diclofenac Monotherapy in Patients with Rheumatoid ArthritisPharmacoEconomics, 1996
- A Comparative Review of Pharmacoeconomic GuidelinesPharmacoEconomics, 1995
- The Costs of Rheumatoid ArthritisPharmacoEconomics, 1994
- A Comparison of the Treatment of Rheumatoid Arthritis in Health Maintenance Organizations and Fee-for-Service PracticesNew England Journal of Medicine, 1985